Literature DB >> 11549345

AlphaB crystallin translocation and phosphorylation: signal transduction pathways and preconditioning in the isolated rat heart.

P Eaton1, W Fuller, J R Bell, M J Shattock.   

Abstract

In this program of studies we have characterized in detail the translocation (assessed by Triton-insolubility) and phosphorylation (using serine-45 or -59 phosphospecific antibodies) of alphaB crystallin during myocardial ischemia [both with or without ischemic preconditioning (IPC)]. Pharmacological activators and inhibitors allowed us to characterize the signaling pathways involved in alphaB crystallin phosphorylation during ischemia. Ischemic preconditioning alone caused 30% of the heart's alphaB crystallin pool to translocate, providing a significant translocation 'head-start' in protected tissue. This enhanced translocation is coupled with increased (3-fold) alphaB crystallin phosphorylation at both serine residues. The possible role of alphaB crystallin in the protection afforded by ischemic preconditioning is supported by the signal transduction data; which showed preconditioning-induced alphaB crystallin phosphorylation can be blocked by tyrosine kinase inhibition (using genistein) and by p38 MAP kinase or PKC inhibition (using SB203580 or bisindolylmaleimide, respectively). The activation of both p38 MAP kinase and PKC are recognized requirements for the induction of preconditioning and their inhibition is known to block protection. Western immunoblotting analysis after isoelectric focusing electrophoresis, confirmed the observations made with the phosphospecific antibodies; but also showed that 27+/-4% of total cardiac crystallin was phosphorylated after 30 min of ischemia. AlphaB crystallin exists as large polymeric aggregates in cardiac tissue under basal conditions (approximately 1 MDa as determined by gel filtration chromatography). We induced phosphorylation of alphaB crystallin during aerobic perfusion by the administration of phenylephrine. However this treatment did not alter the molecular aggregate size of alphaB crystallin. It appears that alphaB crystallin molecular aggregate size is not simply regulated by phosphorylation. AlphaB crystallin may have a role to play in the myocardial protection induced by ischemic preconditioning, as both translocation and phosphorylation are both accelerated and enhanced by ischemic preconditioning. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549345     DOI: 10.1006/jmcc.2001.1418

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

Review 1.  Regulation of αA- and αB-crystallins via phosphorylation in cellular homeostasis.

Authors:  Erin Thornell; Andrew Aquilina
Journal:  Cell Mol Life Sci       Date:  2015-07-26       Impact factor: 9.261

2.  Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion.

Authors:  Hiromitsu Takagi; Chiao-Po Hsu; Katsuya Kajimoto; Dan Shao; Yanfei Yang; Yasuhiro Maejima; Peiyong Zhai; Ghassan Yehia; Chikaomi Yamada; Daniela Zablocki; Junichi Sadoshima
Journal:  Circ Res       Date:  2010-07-01       Impact factor: 17.367

3.  O-GlcNAcylation of αB-crystallin regulates its stress-induced translocation and cytoprotection.

Authors:  Vigneshwaran Krishnamoorthy; Anthony J Donofrio; Jody L Martin
Journal:  Mol Cell Biochem       Date:  2013-03-30       Impact factor: 3.396

Review 4.  The role of αB-crystallin in skeletal and cardiac muscle tissues.

Authors:  Ivan Dimauro; Ambra Antonioni; Neri Mercatelli; Daniela Caporossi
Journal:  Cell Stress Chaperones       Date:  2017-11-30       Impact factor: 3.667

5.  Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation.

Authors:  Giuseppe Vassalli; Giuseppina Milano; Tiziano Moccetti
Journal:  J Transplant       Date:  2012-03-18

Review 6.  Alpha B-Crystallin in Muscle Disease Prevention: The Role of Physical Activity.

Authors:  Ivan Dimauro; Daniela Caporossi
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.